Copyright Reports & Markets. All rights reserved.

Global Urine in Vitro Diagnostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Urine in Vitro Diagnostics by Type
    • 1.3.1 Overview: Global Urine in Vitro Diagnostics Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Urine in Vitro Diagnostics Consumption Value Market Share by Type in 2025
    • 1.3.3 Consumables
    • 1.3.4 Equipment
  • 1.4 Global Urine in Vitro Diagnostics Market by Application
    • 1.4.1 Overview: Global Urine in Vitro Diagnostics Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Drug Testing
    • 1.4.3 Infectious Disease Testing
    • 1.4.4 Other
  • 1.5 Global Urine in Vitro Diagnostics Market Size & Forecast
  • 1.6 Global Urine in Vitro Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Urine in Vitro Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Urine in Vitro Diagnostics Market Size by Region, (2021-2032)
    • 1.6.3 North America Urine in Vitro Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Urine in Vitro Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Urine in Vitro Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.6 South America Urine in Vitro Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Urine in Vitro Diagnostics Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Roche
    • 2.1.1 Roche Details
    • 2.1.2 Roche Major Business
    • 2.1.3 Roche Urine in Vitro Diagnostics Product and Solutions
    • 2.1.4 Roche Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Roche Recent Developments and Future Plans
  • 2.2 Siemens
    • 2.2.1 Siemens Details
    • 2.2.2 Siemens Major Business
    • 2.2.3 Siemens Urine in Vitro Diagnostics Product and Solutions
    • 2.2.4 Siemens Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Siemens Recent Developments and Future Plans
  • 2.3 Abbott
    • 2.3.1 Abbott Details
    • 2.3.2 Abbott Major Business
    • 2.3.3 Abbott Urine in Vitro Diagnostics Product and Solutions
    • 2.3.4 Abbott Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Abbott Recent Developments and Future Plans
  • 2.4 Danaher
    • 2.4.1 Danaher Details
    • 2.4.2 Danaher Major Business
    • 2.4.3 Danaher Urine in Vitro Diagnostics Product and Solutions
    • 2.4.4 Danaher Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Danaher Recent Developments and Future Plans
  • 2.5 Thermo Fisher
    • 2.5.1 Thermo Fisher Details
    • 2.5.2 Thermo Fisher Major Business
    • 2.5.3 Thermo Fisher Urine in Vitro Diagnostics Product and Solutions
    • 2.5.4 Thermo Fisher Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Thermo Fisher Recent Developments and Future Plans
  • 2.6 BioMerieux
    • 2.6.1 BioMerieux Details
    • 2.6.2 BioMerieux Major Business
    • 2.6.3 BioMerieux Urine in Vitro Diagnostics Product and Solutions
    • 2.6.4 BioMerieux Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BioMerieux Recent Developments and Future Plans
  • 2.7 Bio-Rad
    • 2.7.1 Bio-Rad Details
    • 2.7.2 Bio-Rad Major Business
    • 2.7.3 Bio-Rad Urine in Vitro Diagnostics Product and Solutions
    • 2.7.4 Bio-Rad Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bio-Rad Recent Developments and Future Plans
  • 2.8 BD
    • 2.8.1 BD Details
    • 2.8.2 BD Major Business
    • 2.8.3 BD Urine in Vitro Diagnostics Product and Solutions
    • 2.8.4 BD Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 BD Recent Developments and Future Plans
  • 2.9 KHB
    • 2.9.1 KHB Details
    • 2.9.2 KHB Major Business
    • 2.9.3 KHB Urine in Vitro Diagnostics Product and Solutions
    • 2.9.4 KHB Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 KHB Recent Developments and Future Plans
  • 2.10 Daan Gene
    • 2.10.1 Daan Gene Details
    • 2.10.2 Daan Gene Major Business
    • 2.10.3 Daan Gene Urine in Vitro Diagnostics Product and Solutions
    • 2.10.4 Daan Gene Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Daan Gene Recent Developments and Future Plans
  • 2.11 Leadman
    • 2.11.1 Leadman Details
    • 2.11.2 Leadman Major Business
    • 2.11.3 Leadman Urine in Vitro Diagnostics Product and Solutions
    • 2.11.4 Leadman Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Leadman Recent Developments and Future Plans
  • 2.12 Zhongsheng
    • 2.12.1 Zhongsheng Details
    • 2.12.2 Zhongsheng Major Business
    • 2.12.3 Zhongsheng Urine in Vitro Diagnostics Product and Solutions
    • 2.12.4 Zhongsheng Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Zhongsheng Recent Developments and Future Plans
  • 2.13 Bsbe
    • 2.13.1 Bsbe Details
    • 2.13.2 Bsbe Major Business
    • 2.13.3 Bsbe Urine in Vitro Diagnostics Product and Solutions
    • 2.13.4 Bsbe Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Bsbe Recent Developments and Future Plans
  • 2.14 Maccura
    • 2.14.1 Maccura Details
    • 2.14.2 Maccura Major Business
    • 2.14.3 Maccura Urine in Vitro Diagnostics Product and Solutions
    • 2.14.4 Maccura Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Maccura Recent Developments and Future Plans
  • 2.15 Hitachi
    • 2.15.1 Hitachi Details
    • 2.15.2 Hitachi Major Business
    • 2.15.3 Hitachi Urine in Vitro Diagnostics Product and Solutions
    • 2.15.4 Hitachi Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Hitachi Recent Developments and Future Plans
  • 2.16 Canon
    • 2.16.1 Canon Details
    • 2.16.2 Canon Major Business
    • 2.16.3 Canon Urine in Vitro Diagnostics Product and Solutions
    • 2.16.4 Canon Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Canon Recent Developments and Future Plans
  • 2.17 Sysmex
    • 2.17.1 Sysmex Details
    • 2.17.2 Sysmex Major Business
    • 2.17.3 Sysmex Urine in Vitro Diagnostics Product and Solutions
    • 2.17.4 Sysmex Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Sysmex Recent Developments and Future Plans
  • 2.18 Auto Bio
    • 2.18.1 Auto Bio Details
    • 2.18.2 Auto Bio Major Business
    • 2.18.3 Auto Bio Urine in Vitro Diagnostics Product and Solutions
    • 2.18.4 Auto Bio Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Auto Bio Recent Developments and Future Plans
  • 2.19 Mindray
    • 2.19.1 Mindray Details
    • 2.19.2 Mindray Major Business
    • 2.19.3 Mindray Urine in Vitro Diagnostics Product and Solutions
    • 2.19.4 Mindray Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.19.5 Mindray Recent Developments and Future Plans
  • 2.20 Bgi
    • 2.20.1 Bgi Details
    • 2.20.2 Bgi Major Business
    • 2.20.3 Bgi Urine in Vitro Diagnostics Product and Solutions
    • 2.20.4 Bgi Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.20.5 Bgi Recent Developments and Future Plans
  • 2.21 Wondfo
    • 2.21.1 Wondfo Details
    • 2.21.2 Wondfo Major Business
    • 2.21.3 Wondfo Urine in Vitro Diagnostics Product and Solutions
    • 2.21.4 Wondfo Urine in Vitro Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.21.5 Wondfo Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Urine in Vitro Diagnostics Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Urine in Vitro Diagnostics by Company Revenue
    • 3.2.2 Top 3 Urine in Vitro Diagnostics Players Market Share in 2025
    • 3.2.3 Top 6 Urine in Vitro Diagnostics Players Market Share in 2025
  • 3.3 Urine in Vitro Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Urine in Vitro Diagnostics Market: Region Footprint
    • 3.3.2 Urine in Vitro Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Urine in Vitro Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Urine in Vitro Diagnostics Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Urine in Vitro Diagnostics Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Urine in Vitro Diagnostics Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Urine in Vitro Diagnostics Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Urine in Vitro Diagnostics Consumption Value by Type (2021-2032)
  • 6.2 North America Urine in Vitro Diagnostics Market Size by Application (2021-2032)
  • 6.3 North America Urine in Vitro Diagnostics Market Size by Country
    • 6.3.1 North America Urine in Vitro Diagnostics Consumption Value by Country (2021-2032)
    • 6.3.2 United States Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Urine in Vitro Diagnostics Consumption Value by Type (2021-2032)
  • 7.2 Europe Urine in Vitro Diagnostics Consumption Value by Application (2021-2032)
  • 7.3 Europe Urine in Vitro Diagnostics Market Size by Country
    • 7.3.1 Europe Urine in Vitro Diagnostics Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.3 France Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Urine in Vitro Diagnostics Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Urine in Vitro Diagnostics Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Urine in Vitro Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Urine in Vitro Diagnostics Consumption Value by Region (2021-2032)
    • 8.3.2 China Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.5 India Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Urine in Vitro Diagnostics Consumption Value by Type (2021-2032)
  • 9.2 South America Urine in Vitro Diagnostics Consumption Value by Application (2021-2032)
  • 9.3 South America Urine in Vitro Diagnostics Market Size by Country
    • 9.3.1 South America Urine in Vitro Diagnostics Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Urine in Vitro Diagnostics Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Urine in Vitro Diagnostics Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Urine in Vitro Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Urine in Vitro Diagnostics Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Urine in Vitro Diagnostics Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Urine in Vitro Diagnostics Market Drivers
  • 11.2 Urine in Vitro Diagnostics Market Restraints
  • 11.3 Urine in Vitro Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Urine in Vitro Diagnostics Industry Chain
  • 12.2 Urine in Vitro Diagnostics Upstream Analysis
  • 12.3 Urine in Vitro Diagnostics Midstream Analysis
  • 12.4 Urine in Vitro Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Urine in Vitro Diagnostics market size was valued at US$ 25620 million in 2025 and is forecast to a readjusted size of US$ 38000 million by 2032 with a CAGR of 5.9% during review period.
    Urine in vitro diagnostics (IVD) involve the analysis of urine samples to obtain information about various aspects of an individual"s health. Urine is a valuable biological fluid that can provide insights into kidney function, metabolic processes, and the presence of certain substances or markers.
    The Urine In Vitro Diagnostics market is driven by the essential role urine analysis plays in assessing various health conditions. In vitro diagnostic devices dedicated to urine testing, such as urinalysis strips, urine chemistry analyzers, and automated urine sediment analyzers, are instrumental in detecting disorders related to the urinary system, diabetes, kidney diseases, and metabolic conditions. The market benefits from the increasing prevalence of such health issues and the need for efficient and cost-effective diagnostic solutions. The simplicity and non-invasiveness of urine sample collection contribute to the widespread adoption of urine in vitro diagnostics, making it a fundamental component of routine medical examinations and disease management.
    This report is a detailed and comprehensive analysis for global Urine in Vitro Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Urine in Vitro Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Urine in Vitro Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Urine in Vitro Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Urine in Vitro Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Urine in Vitro Diagnostics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Urine in Vitro Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD, KHB, Daan Gene, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Urine in Vitro Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Consumables
    Equipment
    Market segment by Application
    Drug Testing
    Infectious Disease Testing
    Other
    Market segment by players, this report covers
    Roche
    Siemens
    Abbott
    Danaher
    Thermo Fisher
    BioMerieux
    Bio-Rad
    BD
    KHB
    Daan Gene
    Leadman
    Zhongsheng
    Bsbe
    Maccura
    Hitachi
    Canon
    Sysmex
    Auto Bio
    Mindray
    Bgi
    Wondfo
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Urine in Vitro Diagnostics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Urine in Vitro Diagnostics, with revenue, gross margin, and global market share of Urine in Vitro Diagnostics from 2021 to 2026.
    Chapter 3, the Urine in Vitro Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Urine in Vitro Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Urine in Vitro Diagnostics.
    Chapter 13, to describe Urine in Vitro Diagnostics research findings and conclusion.

    Buy now